Summary

The global Animal DR market is projected to grow from US$ 643 million in 2025 to US$ 1941 million by 2032, at a CAGR of 17.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Animal DR refers to digital radiography equipment designed or configured for diagnostic X-ray examination of companion animals, horses, livestock and other veterinary patients. A typical system integrates an X-ray tube, high-voltage generator, collimator, veterinary examination table or mobile support structure, digital flat-panel detector, acquisition workstation and veterinary-specific image-processing software, directly converting transmitted X-rays into digital radiographic images for examination of bones, joints, thoracic structures, abdominal organs, foreign bodies and other abnormalities. Current veterinary DR systems increasingly employ CsI or GOS flat-panel detectors, animal-specific anatomical programmed radiography, automatic exposure detection, rapid image acquisition, wireless data transmission and DICOM/PACS connectivity.
Key Findings
In 2025, global Animal DR production reached approximately 20k units, with an average global market price of around US$32k per unit
Companion-animal DR represents the largest commercial component within the broader Animal DR market
Large-area CsI detectors veterinary protocols and intelligent image processing are becoming mainstream product features
Competition is increasingly shifting from basic hardware toward software workflow connectivity and lifecycle technical service
Market Trends
The Animal DR market is evolving from straightforward digital replacement of film and CR toward integrated veterinary radiography platforms optimized for species diversity, animal positioning and clinical workflow. Fixed systems are increasingly configured with large-area flat-panel detectors, high-frequency generators and veterinary tables designed to simplify positioning for different animal sizes. SEDECAL's NEOVET, for example, offers veterinary-specific configurations with 16 kW, 20 kW and 32 kW generator options, a 43 × 43 cm imaging area and animal-specific APR workflow, while Mindray Animal Medical's VetiX S32 uses a 17 × 17-inch CsI detector and automatically matches exposure settings to animal body size. At the same time, software is becoming increasingly important. Antech SmartDR incorporates veterinary-specific workflows, automatic exposure detection, positioning guidance and machine-learning-based image processing, indicating that consistent diagnostic output across different operators is becoming a central product objective. Mobile systems are also becoming lighter, more wireless and more rugged for equine and field use. Overall technology development is moving toward lower-dose acquisition, faster image availability, wireless detectors, intelligent image optimization and tighter integration with PACS and remote radiology.
Market Dynamics
Drivers
The principal growth drivers include continuing digitalization of veterinary practices, expansion of companion-animal and specialty veterinary services, replacement of CR systems, and growing demand for rapid diagnostic imaging in routine and emergency care. Digital radiography is one of the most broadly applicable imaging technologies in veterinary medicine because it can rapidly support diagnosis of fractures, orthopedic abnormalities, thoracic disease, abdominal conditions and foreign bodies while requiring substantially less capital and infrastructure than CT or MRI. Increasing scale of veterinary hospital networks also favors standardized digital platforms that provide consistent exposure protocols, image processing and centralized image management across multiple sites. Demand is not limited to companion animals: horses and livestock create a distinct market for mobile radiography because these animals frequently cannot be transported or positioned on conventional fixed tables. Antech maintains both fixed veterinary DR and dedicated portable equine DR product families, illustrating the importance of these differentiated demand pools.
Restraints
Market development is constrained by equipment investment, long replacement cycles, hardware commoditization and differences in veterinary infrastructure across regions. A complete fixed system requires an X-ray tube and generator, detector, veterinary table, workstation and radiation-protection arrangements, which can remain a meaningful capital purchase for smaller clinics. Practices with functioning CR or earlier-generation DR equipment may delay replacement if existing systems continue to meet clinical requirements. Flat-panel detectors are also among the most valuable and physically vulnerable components, especially in mobile, equine and livestock applications where equipment may be exposed to drops, vibration, dust, moisture and outdoor operating conditions. Increasing availability of standardized detectors and generators places further pressure on hardware pricing, reducing opportunities for differentiation based purely on specifications. Suppliers therefore increasingly need strong imaging software, veterinary protocols, detector warranties, clinical training and local technical service to sustain product value.
Opportunities
The market offers substantial opportunities across companion-animal hospital upgrades, mobile equine and livestock DR, intelligent image processing and emerging-market digitalization. In developed veterinary markets, replacement demand increasingly favors higher-quality detectors, lower-dose imaging, advanced processing and integrated PACS connectivity. In developing markets, conversion from film or CR to DR creates a broader volume opportunity because digital systems can improve throughput without requiring the infrastructure investment associated with CT or MRI. Mobile systems represent another attractive segment: Antech's Fusion Equine DR combines wireless detector options, a rugged workstation and portable transport configuration specifically for field veterinarians. Software is also opening new value pools through automated animal protocols, positioning support, intelligent contrast and detail optimization, cloud image management and tele-radiology integration. These capabilities can reduce dependence on operator experience and extend advanced interpretation services to smaller hospitals that do not employ full-time veterinary radiologists.
Challenges
A central challenge is maintaining stable diagnostic image quality across a highly diverse patient population ranging from small companion animals to large dogs, horses and livestock. Tissue thickness, anatomy, positioning and exposure requirements vary widely, so Animal DR requires broader protocol flexibility than narrowly defined human examination workflows. Animal cooperation is another issue because patients cannot voluntarily follow positioning or breath-hold instructions, increasing the importance of rapid exposure, mechanical positioning aids and species-specific protocols. Detector robustness becomes particularly important for field systems. Antech's portable equine products emphasize rugged workstations, weather-resistant equipment and portable cases, reflecting the harsher operating environment outside conventional hospitals. Manufacturers must also maintain compatibility between generators, detectors, acquisition software and hospital IT systems. As hardware platforms become increasingly standardized, developing defensible differentiation through proprietary image processing, user experience and service infrastructure is becoming progressively harder.
Industry Chain Analysis
The upstream Animal DR industry includes X-ray tubes, high-voltage generators, collimators, flat-panel detectors, scintillator materials such as CsI and GOS, amorphous-silicon arrays, acquisition electronics, computing hardware, veterinary examination tables, portable stands and wireless modules. Midstream manufacturers integrate these components with image-acquisition software, animal-specific exposure protocols, positioning tools and image-processing algorithms to build complete fixed and mobile veterinary DR solutions. Representative manufacturers and product providers include Siemens Healthineers, Antech Diagnostics and Mindray Animal Medical. Siemens offers the dedicated SHARP VET veterinary radiography platform, Antech has both fixed SmartDR and mobile equine DR systems, and Mindray's VetiX S32 is positioned as a professional animal DR imaging platform. Downstream customers include pet hospitals, general veterinary clinics, specialty and referral centers, equine practices, livestock veterinarians, university veterinary hospitals and animal research institutions. Value creation increasingly extends beyond equipment integration into software, installation, application training, detector replacement, maintenance and remote image-management services.
Segment Insights
Fixed Animal DR systems form the core installed configuration in veterinary hospitals and clinics where radiography is performed repeatedly in a dedicated imaging area. These products generally integrate a stationary generator, X-ray tube, animal table, large-area detector and acquisition workstation, enabling standardized positioning and relatively high examination throughput. Siemens Healthineers' SHARP VET is designed around veterinary positioning, accommodates a broad range of animal sizes and offers different footprint options, while SEDECAL's NEOVET combines a veterinary table, large imaging area and dedicated animal APR workflow. Fixed systems are especially important in companion-animal practice, where chest, abdomen and orthopedic radiographs account for frequent routine imaging demand.
Mobile Animal DR systems target situations where the patient cannot conveniently be brought to a fixed radiography room or where imaging is performed at multiple locations. Typical configurations combine a portable X-ray generator, wireless flat-panel detector, rugged tablet or laptop and battery-powered accessories. This format is particularly relevant to equine and livestock medicine, where imaging may occur in stables, farms or field environments. Antech's Fusion Equine DR and Fusion Lite Equine DR illustrate this segment through portable cases, wireless panel options and rugged workstations designed for mobile veterinarians. The distinction between Fixed and Mobile DR therefore reflects differences not only in mechanical installation, but also in animal type, clinical setting, equipment durability and workflow.
Downstream Market Opportunities
Companion-animal hospitals and clinics represent the broadest downstream demand base because radiography is routinely used in general medicine, orthopedics, cardiopulmonary assessment, abdominal diagnosis and emergency care. Specialty and referral hospitals generate demand for higher-end systems offering advanced processing, standardized protocols and comprehensive PACS connectivity. Equine and livestock practices create a separate opportunity centered on portable equipment, wireless detectors and durable field operation. Veterinary teaching hospitals and research institutions require broader species coverage and extensive image archiving capabilities. Another emerging opportunity comes from tele-radiology: because DR images are inherently digital and compatible with standardized image-management environments, clinics can transmit studies to remote specialists for interpretation. This improves the clinical value of DR equipment in locations where veterinary radiologists are scarce and supports broader adoption outside major metropolitan referral centers.
Regional Insights
North America is a mature Animal DR market with high penetration of digital radiography across companion-animal and equine practices, developed specialty veterinary networks and strong demand for software and technical service. Antech's broad portfolio of fixed and mobile veterinary DR systems reflects the region's differentiated clinical requirements. Europe also has an established veterinary healthcare system and a strong professional equipment base, with companies such as SEDECAL supplying veterinary-specific digital radiography systems. Asia-Pacific is an important development region as companion-animal hospitals expand, CR systems are replaced and domestic medical-imaging manufacturers increase their presence in veterinary equipment. China has developed a broad manufacturing ecosystem ranging from complete animal DR systems to X-ray generators and detectors, while companies such as Mindray Animal Medical are moving toward dedicated professional veterinary platforms. Emerging regions remain more price-sensitive and therefore provide stronger opportunities for cost-effective fixed systems and compact mobile solutions.
Competitive Landscape Analysis
The Animal DR market combines traditional medical imaging manufacturers, dedicated veterinary imaging suppliers and specialized animal medical equipment companies. Representative participants include Siemens Healthineers, Antech Diagnostics and Mindray Animal Medical. Siemens competes through SHARP VET and its established radiography technology base; Antech has a particularly broad veterinary-oriented portfolio covering fixed SmartDR systems and portable equine products; Mindray Animal Medical integrates dedicated animal X-ray technology, large-area CsI detection and animal-specific exposure protocols within the VetiX platform. Competition increasingly centers on detector quality, exposure stability, image-processing algorithms, animal positioning, portability, software usability, DICOM/PACS compatibility, warranty terms and after-sales response. As core hardware becomes more standardized, vendors with stronger veterinary-specific workflow design, clinical support and lifecycle service capabilities are likely to sustain greater differentiation.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Animal DR market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Siemens Healthineers
General Electric
Carestream Health
Antech Diagnostics
Animage Fidex
Epica Animal Health
Neurologica Corp
Hitachi Medical
Esaote
Molecubes
Mediso Medical
Sedecal
SinoVision
Pingsheng Healthcare
Tutom Animal Medical Equipment
DBC Inc.
Mindray Animal Medical
Neusoft Medical
United Imaging Healthcare
Minfound
Vetoo Med
Dawei Veterinary Medical
Wandong Medical
BK Healthcare
iPetMed
Bizvet
DT Healthcare
Ruishi Medical
Segment by Type
Fixed
Mobile
Portable
Segment by Detector Size
14×17-inch
17×17-inch
Segment by Detector Materials
CsI Flat-panel Detector
GOS Flat-panel Detector
Segment by Application
Pets Hospital
Pet Clinic
Research Institutions
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Animal DR study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Animal DR: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Animal DR Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Fixed
1.2.3 Mobile
1.2.4 Portable
1.3 Market Segmentation by Detector Size
1.3.1 Global Animal DR Market Size by Detector Size, 2021 vs 2025 vs 2032
1.3.2 14×17-inch
1.3.3 17×17-inch
1.4 Market Segmentation by Detector Materials
1.4.1 Global Animal DR Market Size by Detector Materials, 2021 vs 2025 vs 2032
1.4.2 CsI Flat-panel Detector
1.4.3 GOS Flat-panel Detector
1.5 Market Segmentation by Application
1.5.1 Global Animal DR Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Pets Hospital
1.5.3 Pet Clinic
1.5.4 Research Institutions
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Animal DR Revenue Estimates and Forecasts (2021-2032)
2.2 Global Animal DR Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Animal DR Sales Estimates and Forecasts (2021-2032)
2.4 Global Animal DR Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Animal DR Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Animal DR Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Fixed: Market Share by Key Manufacturers
3.5.2 Mobile: Market Share by Key Manufacturers
3.5.3 Portable: Market Share by Key Manufacturers
3.6 Global Animal DR Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Animal DR Sales Performance by Type
4.1.1 Global Animal DR Sales Volume by Type (2021-2032)
4.1.2 Global Animal DR Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Animal DR Sales Performance by Detector Size
4.2.1 Global Animal DR Sales Volume by Detector Size (2021-2032)
4.2.2 Global Animal DR Revenue by Detector Size (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Detector Size (2021-2032)
4.3 Global Animal DR Sales Performance by Detector Materials
4.3.1 Global Animal DR Sales Volume by Detector Materials (2021-2032)
4.3.2 Global Animal DR Revenue by Detector Materials (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Detector Materials (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Animal DR Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Animal DR Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Animal DR Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Animal DR Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Animal DR Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Animal DR Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Animal DR Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Animal DR Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Animal DR Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Animal DR Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Animal DR Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Animal DR Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Corporation Information
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers Animal DR Product Models, Descriptions and Specifications
11.1.4 Siemens Healthineers Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Siemens Healthineers Animal DR Sales by Product in 2025
11.1.6 Siemens Healthineers Animal DR Sales by Application in 2025
11.1.7 Siemens Healthineers Animal DR Sales by Geographic Area in 2025
11.1.8 Siemens Healthineers Animal DR SWOT Analysis
11.1.9 Siemens Healthineers Recent Developments
11.2 General Electric
11.2.1 General Electric Corporation Information
11.2.2 General Electric Business Overview
11.2.3 General Electric Animal DR Product Models, Descriptions and Specifications
11.2.4 General Electric Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 General Electric Animal DR Sales by Product in 2025
11.2.6 General Electric Animal DR Sales by Application in 2025
11.2.7 General Electric Animal DR Sales by Geographic Area in 2025
11.2.8 General Electric Animal DR SWOT Analysis
11.2.9 General Electric Recent Developments
11.3 Carestream Health
11.3.1 Carestream Health Corporation Information
11.3.2 Carestream Health Business Overview
11.3.3 Carestream Health Animal DR Product Models, Descriptions and Specifications
11.3.4 Carestream Health Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Carestream Health Animal DR Sales by Product in 2025
11.3.6 Carestream Health Animal DR Sales by Application in 2025
11.3.7 Carestream Health Animal DR Sales by Geographic Area in 2025
11.3.8 Carestream Health Animal DR SWOT Analysis
11.3.9 Carestream Health Recent Developments
11.4 Antech Diagnostics
11.4.1 Antech Diagnostics Corporation Information
11.4.2 Antech Diagnostics Business Overview
11.4.3 Antech Diagnostics Animal DR Product Models, Descriptions and Specifications
11.4.4 Antech Diagnostics Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Antech Diagnostics Animal DR Sales by Product in 2025
11.4.6 Antech Diagnostics Animal DR Sales by Application in 2025
11.4.7 Antech Diagnostics Animal DR Sales by Geographic Area in 2025
11.4.8 Antech Diagnostics Animal DR SWOT Analysis
11.4.9 Antech Diagnostics Recent Developments
11.5 Animage Fidex
11.5.1 Animage Fidex Corporation Information
11.5.2 Animage Fidex Business Overview
11.5.3 Animage Fidex Animal DR Product Models, Descriptions and Specifications
11.5.4 Animage Fidex Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Animage Fidex Animal DR Sales by Product in 2025
11.5.6 Animage Fidex Animal DR Sales by Application in 2025
11.5.7 Animage Fidex Animal DR Sales by Geographic Area in 2025
11.5.8 Animage Fidex Animal DR SWOT Analysis
11.5.9 Animage Fidex Recent Developments
11.6 Epica Animal Health
11.6.1 Epica Animal Health Corporation Information
11.6.2 Epica Animal Health Business Overview
11.6.3 Epica Animal Health Animal DR Product Models, Descriptions and Specifications
11.6.4 Epica Animal Health Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Epica Animal Health Recent Developments
11.7 Neurologica Corp
11.7.1 Neurologica Corp Corporation Information
11.7.2 Neurologica Corp Business Overview
11.7.3 Neurologica Corp Animal DR Product Models, Descriptions and Specifications
11.7.4 Neurologica Corp Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Neurologica Corp Recent Developments
11.8 Hitachi Medical
11.8.1 Hitachi Medical Corporation Information
11.8.2 Hitachi Medical Business Overview
11.8.3 Hitachi Medical Animal DR Product Models, Descriptions and Specifications
11.8.4 Hitachi Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Hitachi Medical Recent Developments
11.9 Esaote
11.9.1 Esaote Corporation Information
11.9.2 Esaote Business Overview
11.9.3 Esaote Animal DR Product Models, Descriptions and Specifications
11.9.4 Esaote Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Esaote Recent Developments
11.10 Molecubes
11.10.1 Molecubes Corporation Information
11.10.2 Molecubes Business Overview
11.10.3 Molecubes Animal DR Product Models, Descriptions and Specifications
11.10.4 Molecubes Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Molecubes Recent Developments
11.11 Mediso Medical
11.11.1 Mediso Medical Corporation Information
11.11.2 Mediso Medical Business Overview
11.11.3 Mediso Medical Animal DR Product Models, Descriptions and Specifications
11.11.4 Mediso Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Mediso Medical Recent Developments
11.12 Sedecal
11.12.1 Sedecal Corporation Information
11.12.2 Sedecal Business Overview
11.12.3 Sedecal Animal DR Product Models, Descriptions and Specifications
11.12.4 Sedecal Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Sedecal Recent Developments
11.13 SinoVision
11.13.1 SinoVision Corporation Information
11.13.2 SinoVision Business Overview
11.13.3 SinoVision Animal DR Product Models, Descriptions and Specifications
11.13.4 SinoVision Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 SinoVision Recent Developments
11.14 Pingsheng Healthcare
11.14.1 Pingsheng Healthcare Corporation Information
11.14.2 Pingsheng Healthcare Business Overview
11.14.3 Pingsheng Healthcare Animal DR Product Models, Descriptions and Specifications
11.14.4 Pingsheng Healthcare Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Pingsheng Healthcare Recent Developments
11.15 Tutom Animal Medical Equipment
11.15.1 Tutom Animal Medical Equipment Corporation Information
11.15.2 Tutom Animal Medical Equipment Business Overview
11.15.3 Tutom Animal Medical Equipment Animal DR Product Models, Descriptions and Specifications
11.15.4 Tutom Animal Medical Equipment Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Tutom Animal Medical Equipment Recent Developments
11.16 DBC Inc.
11.16.1 DBC Inc. Corporation Information
11.16.2 DBC Inc. Business Overview
11.16.3 DBC Inc. Animal DR Product Models, Descriptions and Specifications
11.16.4 DBC Inc. Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 DBC Inc. Recent Developments
11.17 Mindray Animal Medical
11.17.1 Mindray Animal Medical Corporation Information
11.17.2 Mindray Animal Medical Business Overview
11.17.3 Mindray Animal Medical Animal DR Product Models, Descriptions and Specifications
11.17.4 Mindray Animal Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Mindray Animal Medical Recent Developments
11.18 Neusoft Medical
11.18.1 Neusoft Medical Corporation Information
11.18.2 Neusoft Medical Business Overview
11.18.3 Neusoft Medical Animal DR Product Models, Descriptions and Specifications
11.18.4 Neusoft Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Neusoft Medical Recent Developments
11.19 United Imaging Healthcare
11.19.1 United Imaging Healthcare Corporation Information
11.19.2 United Imaging Healthcare Business Overview
11.19.3 United Imaging Healthcare Animal DR Product Models, Descriptions and Specifications
11.19.4 United Imaging Healthcare Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 United Imaging Healthcare Recent Developments
11.20 Minfound
11.20.1 Minfound Corporation Information
11.20.2 Minfound Business Overview
11.20.3 Minfound Animal DR Product Models, Descriptions and Specifications
11.20.4 Minfound Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Minfound Recent Developments
11.21 Vetoo Med
11.21.1 Vetoo Med Corporation Information
11.21.2 Vetoo Med Business Overview
11.21.3 Vetoo Med Animal DR Product Models, Descriptions and Specifications
11.21.4 Vetoo Med Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Vetoo Med Recent Developments
11.22 Dawei Veterinary Medical
11.22.1 Dawei Veterinary Medical Corporation Information
11.22.2 Dawei Veterinary Medical Business Overview
11.22.3 Dawei Veterinary Medical Animal DR Product Models, Descriptions and Specifications
11.22.4 Dawei Veterinary Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Dawei Veterinary Medical Recent Developments
11.23 Wandong Medical
11.23.1 Wandong Medical Corporation Information
11.23.2 Wandong Medical Business Overview
11.23.3 Wandong Medical Animal DR Product Models, Descriptions and Specifications
11.23.4 Wandong Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Wandong Medical Recent Developments
11.24 BK Healthcare
11.24.1 BK Healthcare Corporation Information
11.24.2 BK Healthcare Business Overview
11.24.3 BK Healthcare Animal DR Product Models, Descriptions and Specifications
11.24.4 BK Healthcare Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 BK Healthcare Recent Developments
11.25 iPetMed
11.25.1 iPetMed Corporation Information
11.25.2 iPetMed Business Overview
11.25.3 iPetMed Animal DR Product Models, Descriptions and Specifications
11.25.4 iPetMed Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 iPetMed Recent Developments
11.26 Bizvet
11.26.1 Bizvet Corporation Information
11.26.2 Bizvet Business Overview
11.26.3 Bizvet Animal DR Product Models, Descriptions and Specifications
11.26.4 Bizvet Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Bizvet Recent Developments
11.27 DT Healthcare
11.27.1 DT Healthcare Corporation Information
11.27.2 DT Healthcare Business Overview
11.27.3 DT Healthcare Animal DR Product Models, Descriptions and Specifications
11.27.4 DT Healthcare Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 DT Healthcare Recent Developments
11.28 Ruishi Medical
11.28.1 Ruishi Medical Corporation Information
11.28.2 Ruishi Medical Business Overview
11.28.3 Ruishi Medical Animal DR Product Models, Descriptions and Specifications
11.28.4 Ruishi Medical Animal DR Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Ruishi Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Animal DR Industry Chain
12.2 Animal DR Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Animal DR Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Animal DR Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Animal DR Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Animal DR Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Animal DR Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Animal DR Market Size Growth Rate by Detector Size, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Animal DR Market Size Growth Rate by Detector Materials, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Animal DR Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Animal DR Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Animal DR Revenue by Region (US$ Million), 2021-2026
Table 7. Global Animal DR Revenue by Region (US$ Million), 2027-2032
Table 8. Global Animal DR Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Animal DR Sales by Region (K Units), 2021-2026
Table 10. Global Animal DR Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Animal DR Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Animal DR Sales Share by Manufacturers (2021-2026)
Table 14. Global Animal DR Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Animal DR Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Animal DR Revenue, 2025
Table 18. Global Animal DR Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Animal DR Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Animal DR Manufacturing Base and Headquarters
Table 21. Global Animal DR Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Animal DR Sales Volume by Type (K Units), 2021-2026
Table 25. Global Animal DR Sales Volume by Type (K Units), 2027-2032
Table 26. Global Animal DR Revenue by Type (US$ Million), 2021-2026
Table 27. Global Animal DR Revenue by Type (US$ Million), 2027-2032
Table 28. Global Animal DR Sales Volume by Detector Size (K Units), 2021-2026
Table 29. Global Animal DR Sales Volume by Detector Size (K Units), 2027-2032
Table 30. Global Animal DR Revenue by Detector Size (US$ Million), 2021-2026
Table 31. Global Animal DR Revenue by Detector Size (US$ Million), 2027-2032
Table 32. Global Animal DR Sales Volume by Detector Materials (K Units), 2021-2026
Table 33. Global Animal DR Sales Volume by Detector Materials (K Units), 2027-2032
Table 34. Global Animal DR Revenue by Detector Materials (US$ Million), 2021-2026
Table 35. Global Animal DR Revenue by Detector Materials (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Animal DR Sales by Application (K Units), 2021-2026
Table 38. Global Animal DR Sales by Application (K Units), 2027-2032
Table 39. Animal DR High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Animal DR Revenue by Application (US$ Million), 2021-2026
Table 41. Global Animal DR Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Animal DR Growth Accelerators and Market Barriers
Table 45. North America Animal DR Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Animal DR Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Animal DR Growth Accelerators and Market Barriers
Table 48. Europe Animal DR Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Animal DR Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Animal DR Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Animal DR Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Animal DR Growth Accelerators and Market Barriers
Table 53. Southeast Asia Animal DR Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Animal DR Investment Opportunities and Key Challenges
Table 55. Central and South America Animal DR Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Animal DR Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Animal DR Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Siemens Healthineers Corporation Information
Table 59. Siemens Healthineers Description and Major Businesses
Table 60. Siemens Healthineers Product Models, Descriptions and Specifications
Table 61. Siemens Healthineers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Siemens Healthineers Sales Value Proportion by Product in 2025
Table 63. Siemens Healthineers Sales Value Proportion by Application in 2025
Table 64. Siemens Healthineers Sales Value Proportion by Geographic Area in 2025
Table 65. Siemens Healthineers Animal DR SWOT Analysis
Table 66. Siemens Healthineers Recent Developments
Table 67. General Electric Corporation Information
Table 68. General Electric Description and Major Businesses
Table 69. General Electric Product Models, Descriptions and Specifications
Table 70. General Electric Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. General Electric Sales Value Proportion by Product in 2025
Table 72. General Electric Sales Value Proportion by Application in 2025
Table 73. General Electric Sales Value Proportion by Geographic Area in 2025
Table 74. General Electric Animal DR SWOT Analysis
Table 75. General Electric Recent Developments
Table 76. Carestream Health Corporation Information
Table 77. Carestream Health Description and Major Businesses
Table 78. Carestream Health Product Models, Descriptions and Specifications
Table 79. Carestream Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Carestream Health Sales Value Proportion by Product in 2025
Table 81. Carestream Health Sales Value Proportion by Application in 2025
Table 82. Carestream Health Sales Value Proportion by Geographic Area in 2025
Table 83. Carestream Health Animal DR SWOT Analysis
Table 84. Carestream Health Recent Developments
Table 85. Antech Diagnostics Corporation Information
Table 86. Antech Diagnostics Description and Major Businesses
Table 87. Antech Diagnostics Product Models, Descriptions and Specifications
Table 88. Antech Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Antech Diagnostics Sales Value Proportion by Product in 2025
Table 90. Antech Diagnostics Sales Value Proportion by Application in 2025
Table 91. Antech Diagnostics Sales Value Proportion by Geographic Area in 2025
Table 92. Antech Diagnostics Animal DR SWOT Analysis
Table 93. Antech Diagnostics Recent Developments
Table 94. Animage Fidex Corporation Information
Table 95. Animage Fidex Description and Major Businesses
Table 96. Animage Fidex Product Models, Descriptions and Specifications
Table 97. Animage Fidex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Animage Fidex Sales Value Proportion by Product in 2025
Table 99. Animage Fidex Sales Value Proportion by Application in 2025
Table 100. Animage Fidex Sales Value Proportion by Geographic Area in 2025
Table 101. Animage Fidex Animal DR SWOT Analysis
Table 102. Animage Fidex Recent Developments
Table 103. Epica Animal Health Corporation Information
Table 104. Epica Animal Health Description and Major Businesses
Table 105. Epica Animal Health Product Models, Descriptions and Specifications
Table 106. Epica Animal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Epica Animal Health Recent Developments
Table 108. Neurologica Corp Corporation Information
Table 109. Neurologica Corp Description and Major Businesses
Table 110. Neurologica Corp Product Models, Descriptions and Specifications
Table 111. Neurologica Corp Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Neurologica Corp Recent Developments
Table 113. Hitachi Medical Corporation Information
Table 114. Hitachi Medical Description and Major Businesses
Table 115. Hitachi Medical Product Models, Descriptions and Specifications
Table 116. Hitachi Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Hitachi Medical Recent Developments
Table 118. Esaote Corporation Information
Table 119. Esaote Description and Major Businesses
Table 120. Esaote Product Models, Descriptions and Specifications
Table 121. Esaote Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Esaote Recent Developments
Table 123. Molecubes Corporation Information
Table 124. Molecubes Description and Major Businesses
Table 125. Molecubes Product Models, Descriptions and Specifications
Table 126. Molecubes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Molecubes Recent Developments
Table 128. Mediso Medical Corporation Information
Table 129. Mediso Medical Description and Major Businesses
Table 130. Mediso Medical Product Models, Descriptions and Specifications
Table 131. Mediso Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Mediso Medical Recent Developments
Table 133. Sedecal Corporation Information
Table 134. Sedecal Description and Major Businesses
Table 135. Sedecal Product Models, Descriptions and Specifications
Table 136. Sedecal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Sedecal Recent Developments
Table 138. SinoVision Corporation Information
Table 139. SinoVision Description and Major Businesses
Table 140. SinoVision Product Models, Descriptions and Specifications
Table 141. SinoVision Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. SinoVision Recent Developments
Table 143. Pingsheng Healthcare Corporation Information
Table 144. Pingsheng Healthcare Description and Major Businesses
Table 145. Pingsheng Healthcare Product Models, Descriptions and Specifications
Table 146. Pingsheng Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Pingsheng Healthcare Recent Developments
Table 148. Tutom Animal Medical Equipment Corporation Information
Table 149. Tutom Animal Medical Equipment Description and Major Businesses
Table 150. Tutom Animal Medical Equipment Product Models, Descriptions and Specifications
Table 151. Tutom Animal Medical Equipment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Tutom Animal Medical Equipment Recent Developments
Table 153. DBC Inc. Corporation Information
Table 154. DBC Inc. Description and Major Businesses
Table 155. DBC Inc. Product Models, Descriptions and Specifications
Table 156. DBC Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. DBC Inc. Recent Developments
Table 158. Mindray Animal Medical Corporation Information
Table 159. Mindray Animal Medical Description and Major Businesses
Table 160. Mindray Animal Medical Product Models, Descriptions and Specifications
Table 161. Mindray Animal Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Mindray Animal Medical Recent Developments
Table 163. Neusoft Medical Corporation Information
Table 164. Neusoft Medical Description and Major Businesses
Table 165. Neusoft Medical Product Models, Descriptions and Specifications
Table 166. Neusoft Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Neusoft Medical Recent Developments
Table 168. United Imaging Healthcare Corporation Information
Table 169. United Imaging Healthcare Description and Major Businesses
Table 170. United Imaging Healthcare Product Models, Descriptions and Specifications
Table 171. United Imaging Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. United Imaging Healthcare Recent Developments
Table 173. Minfound Corporation Information
Table 174. Minfound Description and Major Businesses
Table 175. Minfound Product Models, Descriptions and Specifications
Table 176. Minfound Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Minfound Recent Developments
Table 178. Vetoo Med Corporation Information
Table 179. Vetoo Med Description and Major Businesses
Table 180. Vetoo Med Product Models, Descriptions and Specifications
Table 181. Vetoo Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Vetoo Med Recent Developments
Table 183. Dawei Veterinary Medical Corporation Information
Table 184. Dawei Veterinary Medical Description and Major Businesses
Table 185. Dawei Veterinary Medical Product Models, Descriptions and Specifications
Table 186. Dawei Veterinary Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Dawei Veterinary Medical Recent Developments
Table 188. Wandong Medical Corporation Information
Table 189. Wandong Medical Description and Major Businesses
Table 190. Wandong Medical Product Models, Descriptions and Specifications
Table 191. Wandong Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Wandong Medical Recent Developments
Table 193. BK Healthcare Corporation Information
Table 194. BK Healthcare Description and Major Businesses
Table 195. BK Healthcare Product Models, Descriptions and Specifications
Table 196. BK Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. BK Healthcare Recent Developments
Table 198. iPetMed Corporation Information
Table 199. iPetMed Description and Major Businesses
Table 200. iPetMed Product Models, Descriptions and Specifications
Table 201. iPetMed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. iPetMed Recent Developments
Table 203. Bizvet Corporation Information
Table 204. Bizvet Description and Major Businesses
Table 205. Bizvet Product Models, Descriptions and Specifications
Table 206. Bizvet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Bizvet Recent Developments
Table 208. DT Healthcare Corporation Information
Table 209. DT Healthcare Description and Major Businesses
Table 210. DT Healthcare Product Models, Descriptions and Specifications
Table 211. DT Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. DT Healthcare Recent Developments
Table 213. Ruishi Medical Corporation Information
Table 214. Ruishi Medical Description and Major Businesses
Table 215. Ruishi Medical Product Models, Descriptions and Specifications
Table 216. Ruishi Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. Ruishi Medical Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources


List of Figures
Figure 1. Animal DR Product Picture
Figure 2. Global Animal DR Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Fixed Product Picture
Figure 4. Mobile Product Picture
Figure 5. Portable Product Picture
Figure 6. Global Animal DR Market Size Growth Rate by Detector Size, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. 14×17-inch Product Picture
Figure 8. 17×17-inch Product Picture
Figure 9. Global Animal DR Market Size Growth Rate by Detector Materials, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. CsI Flat-panel Detector Product Picture
Figure 11. GOS Flat-panel Detector Product Picture
Figure 12. Global Animal DR Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Pets Hospital
Figure 14. Pet Clinic
Figure 15. Research Institutions
Figure 16. Others
Figure 17. Animal DR Report Years Considered
Figure 18. Global Animal DR Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Animal DR Revenue (US$ Million), 2021-2032
Figure 20. Global Animal DR Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Animal DR Revenue-Based Market Share by Region (2021-2032)
Figure 22. Global Animal DR Sales (K Units), 2021-2032
Figure 23. Global Animal DR Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 24. Global Animal DR Sales Market Share by Region (2021-2032)
Figure 25. Top 5 and Top 10 Manufacturers Animal DR Sales Volume Market Share in 2025
Figure 26. Global Animal DR Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Fixed Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Mobile Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Portable Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Global Animal DR Sales Volume-Based Market Share by Type (2021-2032)
Figure 32. Global Animal DR Revenue-Based Market Share by Type (2021-2032)
Figure 33. Global Animal DR ASP by Type (US$/Unit), 2021-2032
Figure 34. Global Animal DR Sales Volume-Based Market Share by Detector Size (2021-2032)
Figure 35. Global Animal DR Revenue-Based Market Share by Detector Size (2021-2032)
Figure 36. Global Animal DR ASP by Detector Size (US$/Unit), 2021-2032
Figure 37. Global Animal DR Sales Volume-Based Market Share by Detector Materials (2021-2032)
Figure 38. Global Animal DR Revenue-Based Market Share by Detector Materials (2021-2032)
Figure 39. Global Animal DR ASP by Detector Materials (US$/Unit), 2021-2032
Figure 40. Global Animal DR Sales Market Share by Application (2021-2032)
Figure 41. Global Animal DR Revenue-Based Market Share by Application (2021-2032)
Figure 42. Global Animal DR ASP by Application (US$/Unit), 2021-2032
Figure 43. North America Animal DR Sales YoY (K Units), 2021-2032
Figure 44. North America Animal DR Revenue YoY (US$ Million), 2021-2032
Figure 45. North America Top 5 Manufacturers Animal DR Sales Revenue (US$ Million) in 2025
Figure 46. North America Animal DR Sales Volume (K Units) by Application (2021-2032)
Figure 47. North America Animal DR Sales Revenue (US$ Million) by Application (2021-2032)
Figure 48. US Animal DR Revenue (US$ Million), 2021-2032
Figure 49. Canada Animal DR Revenue (US$ Million), 2021-2032
Figure 50. Mexico Animal DR Revenue (US$ Million), 2021-2032
Figure 51. Europe Animal DR Sales YoY (K Units), 2021-2032
Figure 52. Europe Animal DR Revenue YoY (US$ Million), 2021-2032
Figure 53. Europe Top 5 Manufacturers Animal DR Sales Revenue (US$ Million) in 2025
Figure 54. Europe Animal DR Sales Volume (K Units) by Application (2021-2032)
Figure 55. Europe Animal DR Sales Revenue (US$ Million) by Application (2021-2032)
Figure 56. Germany Animal DR Revenue (US$ Million), 2021-2032
Figure 57. France Animal DR Revenue (US$ Million), 2021-2032
Figure 58. U.K. Animal DR Revenue (US$ Million), 2021-2032
Figure 59. Italy Animal DR Revenue (US$ Million), 2021-2032
Figure 60. Russia Animal DR Revenue (US$ Million), 2021-2032
Figure 61. Asia-Pacific Animal DR Sales YoY (K Units), 2021-2032
Figure 62. Asia-Pacific Animal DR Revenue YoY (US$ Million), 2021-2032
Figure 63. Asia-Pacific Top 8 Manufacturers Animal DR Sales Revenue (US$ Million) in 2025
Figure 64. Asia-Pacific Animal DR Sales Volume (K Units) by Application (2021-2032)
Figure 65. Asia-Pacific Animal DR Sales Revenue (US$ Million) by Application (2021-2032)
Figure 66. Indonesia Animal DR Revenue (US$ Million), 2021-2032
Figure 67. Japan Animal DR Revenue (US$ Million), 2021-2032
Figure 68. South Korea Animal DR Revenue (US$ Million), 2021-2032
Figure 69. China Taiwan Animal DR Revenue (US$ Million), 2021-2032
Figure 70. India Animal DR Revenue (US$ Million), 2021-2032
Figure 71. Central and South America Animal DR Sales YoY (K Units), 2021-2032
Figure 72. Central and South America Animal DR Revenue YoY (US$ Million), 2021-2032
Figure 73. Central and South America Top 5 Manufacturers Animal DR Sales Revenue (US$ Million) in 2025
Figure 74. Central and South America Animal DR Sales Volume (K Units) by Application (2021-2032)
Figure 75. Central and South America Animal DR Sales Revenue (US$ Million) by Application (2021-2032)
Figure 76. Brazil Animal DR Revenue (US$ Million), 2021-2032
Figure 77. Argentina Animal DR Revenue (US$ Million), 2021-2032
Figure 78. Middle East, and Africa Animal DR Sales YoY (K Units), 2021-2032
Figure 79. Middle East and Africa Animal DR Revenue YoY (US$ Million), 2021-2032
Figure 80. Middle East and Africa Top 5 Manufacturers Animal DR Sales Revenue (US$ Million) in 2025
Figure 81. Middle East and Africa Animal DR Sales Volume (K Units) by Application (2021-2032)
Figure 82. Middle East and Africa Animal DR Sales Revenue (US$ Million) by Application (2021-2032)
Figure 83. GCC Countries Animal DR Revenue (US$ Million), 2021-2032
Figure 84. Turkey Animal DR Revenue (US$ Million), 2021-2032
Figure 85. Egypt Animal DR Revenue (US$ Million), 2021-2032
Figure 86. South Africa Animal DR Revenue (US$ Million), 2021-2032
Figure 87. Animal DR Industry Chain Mapping
Figure 88. Regional Animal DR Manufacturing Base Distribution (%)
Figure 89. Global Animal DR Production Market Share by Region (2021-2032)
Figure 90. Animal DR Production Process
Figure 91. Regional Animal DR Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed